|
|
| Line 1: |
Line 1: |
| − | '''The Association of the British Pharmaceutical Industry''' (ABPI) is a lobby group representing the interests of numerous British pharmaceutical companies. Currently ABPI's memberlist numbers 75 companies including some of the largest such as [[GlaxoSmithKline]] and [[AstraZeneca]]. It is active at both the British and European level and has in addition been involved in lobbying for pharmaceutical interests in the devolved institutions of Wales and Scotland.
| |
| | | | |
| − | ==Active Areas==
| |
| − |
| |
| − | The ABPI has lobbied for the interests of its members in a number of areas, issues which it has supported include -
| |
| − |
| |
| − | *Patents for biotechnological inventions
| |
| − | *Patents for medicines in developing countries
| |
| − | *A loosening of restrictions on advertising prescription medicines
| |
| − | *Public-Private-Partnerships to fund research
| |
| − | *An opposition to lowering the prices of pharmaceutical products
| |
| − | *An opposition to legal obligations to disclose research data
| |
| − | *The right to use Animals in research
| |
| − |
| |
| − |
| |
| − | ==Patents in Developing countries==
| |
| − |
| |
| − | One of the areas in which ABPI has been most vocal concerns the patenting of medicines in developing countries.
| |
